Anthony Barrett
11Patents
5h-index
23Co-inventors
66Inventor score
Filing activity: Mar 14, 1995 → Feb 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8540967B2 | Porphyrazine optical and dual optical/MR contrast and therapeutic agents | Human Necessities | 54 | Active |
| US5675001A | Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom | Chemistry; Metallurgy | 24 | Expired |
| US5912341A | Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom | Chemistry; Metallurgy | 18 | Expired |
| US9932344B2 | Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use | Human Necessities | 10 | Active |
| US8067424B2 | Selective inhibitors for cyclin-dependent kinases | Chemistry; Metallurgy | 7 | Active |
| US10414772B2 | Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use | Human Necessities | 2 | Active |
| US10927119B2 | Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use | Human Necessities | 1 | Active |
| US11857552B2 | 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8507673B2 | Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compounds | Chemistry; Metallurgy | 0 | Active |
| US8311783B2 | Method for the generation of a set of conflicts for model-based system diagnostics, and corresponding diagnostic method | Physics | 0 | Active |
| US11566029B2 | Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.